Clinical Trial Update: Safety Study of Hemospan® in Prostatectomy Patients [Phase 2]

View source ↗

Summary

Phase 2 safety study of Hemospan in prostatectomy patients has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Hemospan

Snippet

Sponsor: Sangart | Conditions: Blood Loss, Surgical, Prostate Cancer | Phase 2 | Status: COMPLETED